Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Momenta Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 20.25M 116.77M 283.07M 63.92M 35.47M
Cost of Goods Sold (COGS) incl. D&A 4.8M 4.7M 5.52M - -
COGS excluding D&A 0 0 0 - -
Depreciation & Amortization Expense 4.8M 4.7M 5.52M 7.48M 8.17M
Depreciation 4.47M 4.4M 4.1M 6.42M 7.11M
Amortization of Intangibles 326,000 299,000 1.42M 1.06M 1.06M
Gross Income 15.45M 112.07M 277.55M - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 79.62M 75.61M 93.35M 116.55M 136.89M
Research & Development 60.61M 51.71M 64.66M 80.35M 104M
Other SG&A 19M 23.9M 28.7M 36.2M 32.89M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 4.5M - -
EBIT after Unusual Expense 0 0 (4.5M) - -
Non Operating Income/Expense (104,000) 978,000 0 220,000 233,000
Non-Operating Interest Income 825,000 176,000 746,000 1.24M 950,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 570,000 329,000 91,000 0 0
Gross Interest Expense 570,000 329,000 91,000 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Minority Interest Expense 0 0 0 0 0
Net Income (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (64.01M) 37.29M 180.36M (58.65M) (108.41M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (64.01M) 37.29M 180.36M (58.65M) (108.41M)
EPS (Basic) (1.60) 0.84 3.62 (1.16) (2.13)
Basic Shares Outstanding 40.06M 44.63M 49.85M 50.41M 50.91M
EPS (Diluted) (1.60) 0.81 3.55 (1.16) (2.13)
Diluted Shares Outstanding 40.06M 45.94M 50.82M 50.41M 50.91M
EBITDA (59.37M) 41.17M 189.72M (52.63M) (101.42M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.